BIOSERGEN AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3 SEK | -2.60% |
|
-12.28% | -65.91% |
| Apr. 09 | Biosergen to Issue New Units as Compensation Under Rights Issue | MT |
| Mar. 27 | Biosergen Raises SEK26.4 Million via Rights Issue | MT |
Chart calendar Biosergen AB
96.QR6RJIkDnRochWgevDFWnyBGSZFAY04WqBIDC2GkFAg.NE3LEeh7sG159y9bhHAC03gJB90VECwg42JbZg3mJkkeTeh1zHv3TVH3JQ~08ea1e42b78ac35780e28af6310ad2a4
Upcoming events on Biosergen AB
Past events on Biosergen AB
| 2024-03-28 | Q4 2023 Earnings Release |
| 2023-12-05 | Carlsquare Nordic Life Science Investor Day |
| 2023-11-29 | Q3 2023 Earnings Release |
| 2023-08-30 | Q2 2023 Earnings Release |
| 2023-05-30 | Annual General Meeting |
| 2023-05-30 | Q1 2023 Earnings Release |
| 2023-03-30 | Q4 2022 Earnings Release |
| 2022-11-29 | Q3 2022 Earnings Release |
| 2022-08-31 02:49 am | Interim 2022 Earnings Release |
| 2022-05-31 03:00 am | Q1 2022 Earnings Release |
| 2022-04-27 | Annual General Meeting |
| 2022-03-30 | FY 2021 Earnings Release |
| 2021-11-29 | Q3 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 |
|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 | 5,18 3,20 61.97% | 0,00 |
|
EBITDA Million SEK | Released Forecast Spread | 0,00 | -40,0 -40,5 1.27% | 0,00 |
|
EBIT Million SEK | Released Forecast Spread | 0,00 | -40,0 -40,5 1.27% | 0,00 |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
Net income Million SEK | Released Forecast Spread | -34,3 | 0,00 0,00 - | -27,0 |
|
EPS SEK | Released Forecast Spread | -1,42 | 0,00 0,00 - | -0,53 |
| Announcement Date | 31/03/22 | 31/03/23 | 29/02/24 |
Quarterly results
| Fiscal Period | December | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2024 Q1 | 2024 Q2 |
|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 1,96 0,00 - | 5,32 0,00 - | 2,46 0,00 - | 0,00 | 0,00 |
|
EBITDA Million SEK | Released Forecast Spread | -12,5 -15,8 20.94% | -5,03 -21,6 76.72% | -8,04 -21,6 62.79% | -6,90 | -6,90 |
|
EBIT Million SEK | Released Forecast Spread | -12,5 -15,8 20.94% | -5,03 -21,6 76.72% | -8,04 -21,6 62.79% | -6,90 | -6,90 |
| Announcement Date | 31/03/23 | 31/05/23 | 14/08/23 | - | - |
| 2024-05-15 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 09:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-07-23 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-25 01:00 am | ARGENX SE: Q2 2024 Earnings Release |
| 2024-07-29 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-30 | CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Biosergen AB
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BIOSGN Stock
- Calendar Biosergen AB